HCQS 300 mg Ipca Laboratories Ltd

£28.00

HCQS 300 mg Ipca Laboratories Ltd is a pharmaceutical-grade hydroxychloroquine formulation designed for controlled research investigations into antimalarial and autoimmune pathway mechanisms under laboratory conditions.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
HCQS 300 mg Ipca Laboratories Ltd
HCQS 300 mg Ipca Laboratories Ltd
£28.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview of HCQS 300 mg

HCQS 300 mg Ipca Laboratories Ltd is a pharmaceutical-grade hydroxychloroquine sulfate formulation manufactured for comprehensive research applications. This established antimalarial compound enables investigators to examine immunomodulatory pathways, autophagy mechanisms, and cellular pH regulation in controlled laboratory environments. Researchers at Stroid UK Shop can utilise this formulation to investigate hydroxychloroquine’s established mechanisms of action across various research protocols.

Laboratory Research Applications

Research scientists analyse HCQS 300 mg to investigate its established mechanisms in antimalarial research, autoimmune pathway modulation, and cellular organelle function studies. The compound’s ability to interfere with lysosomal acidification makes it valuable for autophagy research, while its immunomodulatory properties enable investigation of inflammatory cascade mechanisms. Studies often examine its effects on toll-like receptor signalling, interferon production pathways, and complement activation processes. Investigators working with dermatological research compounds frequently incorporate hydroxychloroquine studies alongside other immunomodulatory agents. Research applications extend to examining its effects on antigen presentation, T-cell activation, and cytokine production in various cell culture models. Scientists also investigate its potential interactions with other research compounds from categories including SARMs and peptides in comprehensive research protocols.

Technical Specifications

HCQS 300 mg Product Specifications
Active Ingredient Hydroxychloroquine Sulfate
Strength 300 mg per tablet
Manufacturer Ipca Laboratories Ltd
CAS Number 747-36-4
Molecular Formula C₁₈H₂₈ClN₃O₅S
Storage Requirements Room temperature, dry environment
Form Film-coated tablets

Research Compliance Statement

HCQS 300 mg Ipca Laboratories Ltd is supplied exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with all applicable regulations and institutional guidelines when conducting studies with this compound.

Related